Rochester Drug Co-Operative Inc. v. Braintree Laboratories Inc.

  1. January 20, 2012

    Braintree, Buyers Settle Generic MiraLax Suit For $17M

    Drug buyer plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal judge Friday to approve a $17.25 million settlement of direct purchaser claims.

  2. July 07, 2011

    MiraLax Plaintiffs Win Injunction Against Braintree

    A federal judge in Delaware ruled Thursday that Braintree Laboratories Inc. must continue to do business with direct purchasers who filed a putative antitrust class action accusing the company of initiating baseless patent litigation to block a generic version of the laxative MiraLax.

  3. April 22, 2011

    Plaintiffs Fear Retaliation In MiraLax Antitrust Suit

    Plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal court Thursday to bar the company from retaliating against them.